Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A V Potekhina

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Kardiologiia|December 26, 2017
[Left ventricular dysfunction in hypertensive heart: Current view of the pathogenesis and treatment]F T Ageev, A G Ovchinnikov, M V Ozhereljeva, et al.
Biochemistry. Biokhimiia|September 14, 2018
Immunotropic Effects and Proposed Mechanism of Action for 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase Inhibitors (Statins)T I Arefieva, A Yu Filatova, A V Potekhina, et al.
Kardiologiia|May 14, 2024
[Anthracycline-induced Heart Failure: Treatment and Recovery Prospects]M V Vitsenya, A V Potekhina, A Yu Filatova, et al.
Kardiologiia|July 26, 2019
[Mechanisms of exercise intolerance in patients with heart failure and preserved ejection fraction. Part I: The role of impairments in the left heart chambers]A G Ovchinnikov, A V Potekhina, N M Ibragimova, et al.
Acta Naturae|August 4, 2020
The Molecular and Cellular Mechanisms Associated with a Microvascular Inflammation in the Pathogenesis of Heart Failure with Preserved Ejection FractionA G Ovchinnikov, T I Arefieva, A V Potekhina, et al.
Kardiologiia|September 19, 2019
[Mechanisms of exercise intolerance in patients with heart failure and preserved ejection fraction. Part II: The role of right heart chambers, vascular system and skeletal muscles]A G Ovchinnikov, A V Potekhina, N M Ibragimova, et al.
Terapevticheskii Arkhiv|October 16, 2009
[The influence of coronary stenting with rapamycin-eluting stents on the number of circulating CD4+CD25high+regulatory T-cells]T I Aref'eva, S I Provatorov, A V Potekhina, et al.
Bulletin of Experimental Biology and Medicine|January 12, 2012
Changes in the concentration of monocytic chemotaxic protein-1 in patients with unstable angina treated with arixtraA V Potekhina, T I Arefieva, T L Krasnikova, et al.
Kardiologiia|December 5, 2024
[The Role of the Left Atrium in the Pathogenesis of Heart Failure With Preserved Ejection Fraction]A G Ovchinnikov, A V Potekhina, A Yu Filatova, et al.
Terapevticheskii Arkhiv|December 30, 2023
[Effects of sacubitril/valsartan in patients with cancer therapy-related heart failure]M V Vitsenya, A V Potekhina, S V Gavryushina, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Kardiologiia|December 26, 2017
[Left ventricular dysfunction in hypertensive heart: Current view of the pathogenesis and treatment]F T Ageev, A G Ovchinnikov, M V Ozhereljeva, et al.
Biochemistry. Biokhimiia|September 14, 2018
Immunotropic Effects and Proposed Mechanism of Action for 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase Inhibitors (Statins)T I Arefieva, A Yu Filatova, A V Potekhina, et al.
Kardiologiia|May 14, 2024
[Anthracycline-induced Heart Failure: Treatment and Recovery Prospects]M V Vitsenya, A V Potekhina, A Yu Filatova, et al.
Kardiologiia|July 26, 2019
[Mechanisms of exercise intolerance in patients with heart failure and preserved ejection fraction. Part I: The role of impairments in the left heart chambers]A G Ovchinnikov, A V Potekhina, N M Ibragimova, et al.
Acta Naturae|August 4, 2020
The Molecular and Cellular Mechanisms Associated with a Microvascular Inflammation in the Pathogenesis of Heart Failure with Preserved Ejection FractionA G Ovchinnikov, T I Arefieva, A V Potekhina, et al.
Kardiologiia|September 19, 2019
[Mechanisms of exercise intolerance in patients with heart failure and preserved ejection fraction. Part II: The role of right heart chambers, vascular system and skeletal muscles]A G Ovchinnikov, A V Potekhina, N M Ibragimova, et al.
Terapevticheskii Arkhiv|October 16, 2009
[The influence of coronary stenting with rapamycin-eluting stents on the number of circulating CD4+CD25high+regulatory T-cells]T I Aref'eva, S I Provatorov, A V Potekhina, et al.
Bulletin of Experimental Biology and Medicine|January 12, 2012
Changes in the concentration of monocytic chemotaxic protein-1 in patients with unstable angina treated with arixtraA V Potekhina, T I Arefieva, T L Krasnikova, et al.
Kardiologiia|December 5, 2024
[The Role of the Left Atrium in the Pathogenesis of Heart Failure With Preserved Ejection Fraction]A G Ovchinnikov, A V Potekhina, A Yu Filatova, et al.
Terapevticheskii Arkhiv|December 30, 2023
[Effects of sacubitril/valsartan in patients with cancer therapy-related heart failure]M V Vitsenya, A V Potekhina, S V Gavryushina, et al.
Pageof 3